Peru Pharmaceuticals & Healthcare Report Q2 2018
Political gridlock and uncertainty will weigh on pharmaceutical investment in Peru, as sentiment sours and thegovernment struggles to get public projects back on line. Further, legislative gridlock hindered policy formation over the course of2017 and is set to continue in 2018 after a failed impeachment attempt of President Pedro Pablo Kuczynski. Nonetheless, strongmining sector activity will drive an acceleration in growth and further support the concerted efforts to extend health coverage toremoter regions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook